Authors:
KOHN EC
ALESSANDRO R
SPOONSTER J
WERSTO RP
LIOTTA LA
Citation: Ec. Kohn et al., ANGIOGENESIS - ROLE OF CALCIUM-MEDIATED SIGNAL-TRANSDUCTION, Proceedings of the National Academy of Sciences of the United Statesof America, 92(5), 1995, pp. 1307-1311
Citation: Ec. Kohn et La. Liotta, MOLECULAR INSIGHTS INTO CANCER INVASION - STRATEGIES FOR PREVENTION AND INTERVENTION, Cancer research, 55(9), 1995, pp. 1856-1862
Authors:
KOHN EC
SAROSY G
BICHER A
LINK C
CHRISTIAN M
STEINBERG SM
ROTHENBERG M
ADAMO DO
DAVIS P
OGNIBENE FP
CUNNION RE
REED E
Citation: Ec. Kohn et al., DOSE-INTENSE TAXOL - HIGH RESPONSE RATE IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OVARIAN-CANCER, Journal of the National Cancer Institute, 86(1), 1994, pp. 18-24
Citation: Kd. Rodland et al., INHIBITION OF PHOSPHOLIPASE-A2 BLOCKS THE ABILITY OF CAI, A NOVEL CHEMOTHERAPEUTIC AGENT, TO INDUCE IMMEDIATE-EARLY GENE-EXPRESSION, Journal of cellular biochemistry, 1994, pp. 34-34
Authors:
KOHN EC
JACOBS W
KIM YS
ALESSANDRO R
STETLERSTEVENSON WG
LIOTTA LA
Citation: Ec. Kohn et al., CALCIUM INFLUX MODULATES EXPRESSION OF MATRIX METALLOPROTEINASE-2 (72-KDA TYPE-IV COLLAGENASE, GELATINASE-A), The Journal of biological chemistry, 269(34), 1994, pp. 21505-21511
Citation: Sa. Savage et Ec. Kohn, CALCIUM SIGNAL-TRANSDUCTION TARGETS IN INVASION AND METASTASIS, Bulletin de l'Institut Pasteur, 92(4), 1994, pp. 259-269
Authors:
ISRAEL L
LIOTTA L",RUOSLAHTI,"ALBINO AP
SCHWARTZ GK
REED JA",SASTREGARAU,"GARBISA S",YOKOTA,KERBEL,SAVAGE,"KOHN EC
BARLATI S
ZUCKER S
Citation: L. Israel et al., METASTASES - 1ST FORUM IN THE BULLETIN DE LINSTITUT PASTEUR - DISCUSSION, Bulletin de l'Institut Pasteur, 92(4), 1994, pp. 299-312
Authors:
KOHN EC
FELDER CC
JACOBS W
HOLMES KA
DAY A
FREER R
LIOTTA LA
Citation: Ec. Kohn et al., STRUCTURE-FUNCTION ANALYSIS OF SIGNAL AND GROWTH-INHIBITION BY CARBOXYAMIDO-TRIAZOLE, CAI, Cancer research, 54(4), 1994, pp. 935-942
Authors:
LINK CJ
BICHER A
KOHN EC
CHRISTIAN MC
DAVIS PA
ADAMO DO
REED E
SAROSY GA
Citation: Cj. Link et al., FLEXIBLE GRANULOCYTE-COLONY-STIMULATING FACTOR DOSING IN OVARIAN-CANCER PATIENTS WHO RECEIVE DOSE-INTENSE TAXOL THERAPY, Blood, 83(5), 1994, pp. 1188-1192